140 related articles for article (PubMed ID: 27785332)
1. Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Involving the Colon in a Patient With Ulcerative Pancolitis and Polymyositis on Long-Term Methotrexate Therapy.
Chang MD; Markham MJ; Liu X
Gastroenterology Res; 2016 Oct; 9(4-5):83-86. PubMed ID: 27785332
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders.
Ejima-Yamada K; Oshiro Y; Okamura S; Fujisaki T; Mihashi Y; Tamura K; Fukushige T; Kojima M; Shibuya K; Takeshita M
Virchows Arch; 2017 Feb; 470(2):205-215. PubMed ID: 27864689
[TBL] [Abstract][Full Text] [Related]
3. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas.
Feng WH; Cohen JI; Fischer S; Li L; Sneller M; Goldbach-Mansky R; Raab-Traub N; Delecluse HJ; Kenney SC
J Natl Cancer Inst; 2004 Nov; 96(22):1691-702. PubMed ID: 15547182
[TBL] [Abstract][Full Text] [Related]
4. A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.
Kinch A; Baecklund E; Backlin C; Ekman T; Molin D; Tufveson G; Fernberg P; Sundström C; Pauksens K; Enblad G
Acta Oncol; 2014 May; 53(5):669-79. PubMed ID: 24164103
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous Methotrexate-Related Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in a Patient with Granulomatous Cutaneous T-Cell Lymphoma: A Case Report and Literature Review.
Kositkuljorn C; Rutnin S; Rattananukrom T; Puavilai T; Khiankaew B; Boonsakan P; Iamsumang W
Clin Cosmet Investig Dermatol; 2023; 16():2229-2235. PubMed ID: 37601419
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
Uccini S; Al-Jadiry MF; Scarpino S; Ferraro D; Alsaadawi AR; Al-Darraji AF; Moleti ML; Testi AM; Al-Hadad SA; Ruco L
Hum Pathol; 2015 May; 46(5):716-24. PubMed ID: 25704629
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus and methotrexate-related CNS lymphoma in a patient with rheumatoid arthritis.
Migita K; Miyashita T; Mijin T; Sakito S; Kurohama H; Ito M; Toda K; Tsustumi K; Baba H; Izumi Y; Kawakami A; Niino D; Ohshima K
Mod Rheumatol; 2013 Jul; 23(4):832-6. PubMed ID: 22825547
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-negative diffuse large B-cell lymphoma hosts intra- and peritumoral B-cells with activated Epstein-Barr virus.
Stuhlmann-Laeisz C; Szczepanowski M; Borchert A; Brüggemann M; Klapper W
Virchows Arch; 2015 Jan; 466(1):85-92. PubMed ID: 25339301
[TBL] [Abstract][Full Text] [Related]
9. [2-year complete remission after withdrawal of methotrexate in a rectal methotrexate-associated diffuse large B-cell lymphoma].
Ogasawara T; Kimura A; Yasuyama M; Ohtuka K; Aiba M; Kawauchi K
Rinsho Ketsueki; 2007 Jun; 48(6):485-90. PubMed ID: 17633096
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis.
Paul C; Le Tourneau A; Cayuela JM; Devidas A; Robert C; Molinié V; Dubertret L
Arch Dermatol; 1997 Jul; 133(7):867-71. PubMed ID: 9236525
[TBL] [Abstract][Full Text] [Related]
11. Case report: lymphoma arising in an ileal pouch anal anastomosis after immunomodulatory therapy for inflammatory bowel disease.
Schwartz LK; Kim MK; Coleman M; Lichtiger S; Chadburn A; Scherl E
Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1030-4. PubMed ID: 16854631
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous regression of Epstein-Barr virus-associated lymphoproliferative disorder in a juvenile idiopathic arthritis patient after the discontinuation of methotrexate and etanercept.
Klein A; Reinhard H; Mueller AM; Horneff G
Eur J Rheumatol; 2017 Jun; 4(2):136-138. PubMed ID: 28638688
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma arising in patient with a history of EBV-positive mucocutaneous ulcer and EBV-positive nodal polymorphous B-lymphoproliferative disorder.
Daroontum T; Kohno K; Inaguma Y; Okamoto A; Okamoto M; Kimura Y; Nagahama M; Sakakibara A; Satou A; Nakamura S
Pathol Int; 2019 Jan; 69(1):37-41. PubMed ID: 30450620
[TBL] [Abstract][Full Text] [Related]
14. Pediatric oral Epstein-Barr virus associated self-remitting CD30+ lymphoproliferative disorder: A distinct entity.
Schwartz Z; Bowe RB; Coleman M; Magro CM
Ann Diagn Pathol; 2018 Dec; 37():57-61. PubMed ID: 30292067
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-positive mucocutaneous ulcer arising in a post-hematopoietic cell transplant patient followed by polymorphic posttransplant lymphoproliferative disorder and cytomegalovirus colitis.
Satou A; Kohno A; Fukuyama R; Elsayed AA; Nakamura S
Hum Pathol; 2017 Jan; 59():147-151. PubMed ID: 27569297
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus in inflammatory bowel disease: the spectrum of intestinal lymphoproliferative disorders.
Nissen LH; Nagtegaal ID; de Jong DJ; Kievit W; Derikx LA; Groenen PJ; van Krieken JH; Hoentjen F
J Crohns Colitis; 2015 May; 9(5):398-403. PubMed ID: 25740811
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-associated lymphoproliferative disease occurring in a patient with sarcoidosis treated by methotrexate and methylprednisolone.
Theate I; Michaux L; Dardenne S; Guiot Y; Brière J; Emile FJ; Fabiani B; Detry R; Gaulard P;
Eur J Haematol; 2002 Oct; 69(4):248-53. PubMed ID: 12431245
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus (EBV) provides survival factors to EBV
Wu L; Ehlin-Henriksson B; Zhou X; Zhu H; Ernberg I; Kis LL; Klein G
Immunology; 2017 Dec; 152(4):562-573. PubMed ID: 28699226
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-related diffuse large B-cell lymphoma type methotrexate-associated lymphoproliferative disorders presenting in the adrenal gland.
Doi K; Muramaki M; Yamamoto T; Katsura D; Fukunaga H; Takahashi K; Matsumoto M; Yamada Y
IJU Case Rep; 2022 May; 5(3):172-174. PubMed ID: 35509787
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders.
Yamada K; Oshiro Y; Okamura S; Fujisaki T; Kondo S; Nakayama Y; Suematsu E; Tamura K; Takeshita M
Histopathology; 2015 Jul; 67(1):70-80. PubMed ID: 25429725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
